5-substituted indazoles as kinase inhibitors

Irini Akritopoulou-Zanze, Libertyville, IL (US);

Brian D. Wakefield, Vernon Hills, IL (US);

Helmut Mack, Ludwigshafen, DE;

Sean C. Turner, Mannheim, DE;

Alan F. Gasiecki, Vernon Hills, IL (US);

Vijaya J. Gracias, West Newton, MA (US);

Kathy A. Sarris, Mundelein, IL (US);

Douglas M. Kalvin, Buffalo Grove, IL (US);

Melissa J. Michmerhuizen, Beach Park, IL (US);

Qi Shuai, Dekalb, IL (US);

Jyoti R. Patel, Libertyville, IL (US);

Margaretha H. M. Bakker, Seeheim-Jugenheim, DE;

Nicole Teusch, Cologne, DE;

Eric F. Johnson, Antioch, IL (US);

Peter J. Kovar, Chicago, IL (US);

Stevan W. Djuric, Libertyville, IL (US);

Andrew J. Long, Chelmsford, MA (US);

Anil Vasudevan, Union Grove, WI (US);

Dawn M. George, Charlton, MA (US);

Lu Wang, Westborough, MA (US);

Biqin Li, Southborough, MA (US);

Nigel S. Moore, Shrewsbury, MA (US);

Adrian D. Hobson, Shrewsbury, MA (US);

Keith W. Woods, Lincolnshire, IL (US);

Julie M. Miyashiro, Morton Grove, IL (US);

Steven L. Swann, Jr., San Diego, CA (US);

Thomas D. Penning, Elmhurst, IL (US);

AbbVie Inc., North Chicago, IL (US);